Patterns of response and acquired resistance to the programmed death‐1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Dermatologic therapy 2019-11, Vol.32 (6), p.e13107-n/a
Hauptverfasser:	Zalaudek, Iris, Corneli, Paola, Vernoni, Sibil, Fedele, Dahlia, Papa, Giovanni, Conforti, Claudio, Retrosi, Chiara, Vezzoni, Roberta, Fagotti, Serena, Longone, Michela, Farinazzo, Eleonora, Meo, Nicola, Pizzichetta, Maria A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal, Humanized - therapeutic use Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - pathology Drug Resistance, Neoplasm Humans Male Neoplasm Staging Programmed Cell Death 1 Receptor - antagonists & inhibitors Skin Neoplasms - drug therapy Skin Neoplasms - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!